Sigma Completes $370 Million Buy of JRH Biosciences

Sigma-Aldrich Corp. has completed its $370 million cash acquisition of JRH Biosciences division of CSL Ltd., it said. Lenexa, Kan.-based JRH Biosciences supplies cell culture and sera products to the biopharmaceutical industry. It had about $150 million in sales in 2004, with a 10 percent increase expected in 2005. The company has 400 employees and manufacturing facilities in the U.S., Europe and Australia and collection and processing centers in the U.S. and Australia.

St. Louis Business Journal (http://www.bizjournals.com/stlouis/stories/2005/02/28/daily17.html)